1-(2-Chloroethyl)pyrrolidine, 98+%, 250mg

(3R,5R)-tert-Butyl 3-amino-5-fluoropiperidine-1-carboxylate, 95.0%, 100mg

(R)-1-(4-Amino-1H-pyrazol-1-yl)propan-2-ol, 97%, 250mg

3'-(Ethylamino)-2'-methyl-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-6'-yl trifluoromethanesulfonate, 97%, 100mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridin-2-amine, 98%, 1g

2-chloro-4-nitro-1H-1,3-benzodiazole, 97%, 1g

Dewar vessel dish-shaped, SCH 31 CAL, 2700 ml, 200 mm, 1 Piece

Tetrahydro-2H-pyran-4-amine>95.0%(GC)(T)5g

(S)-3-(Dimethylamino)-3-phenylpropan-1-ol, 95.0%, 250mg

1,9-Nonanediol>98.0%(GC)100g

3-Methylsulfonylphenylboronic acid, 96.0%, 25g

4-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-5-amine hydrochloride, 95.0%, 1g

2,5-Dihydroxyphenyl(diphenyl)phosphine Oxide>97.0%(GC)5g